AOD-9604 vs Tesamorelin
Both AOD-9604 and Tesamorelin are kept in stock here and are frequently weighed against each other. This page lays out where they diverge: how each is classed, what sizes exist and the per-milligram price, the shape of the evidence published on each, and how Canadian law treats them. It draws no ranking between them, since which one fits turns on what is being studied.
Side by side
| AOD-9604 | Tesamorelin | |
|---|---|---|
| Class | Modified C-terminal fragment of human growth hormone | Growth hormone-releasing hormone (GHRH) analogue |
| Sizes and price | 5 mg — from $57.00 (best $11.40/mg) | 5 mg · 10 mg — from $61.50 (best $8.55/mg) |
| Published evidence | 6 cited studies, all animal or cell work. No human study. | 8 cited studies; 8 controlled trials in people. |
| Models studied | rat, mouse, rabbit | human |
| Status in Canada | No Drug Identification Number; named in a Health Canada advisory | Ingredient is in an authorized Canadian medicine (a different product) |
| Formats | vial, starter | vial, starter |
Key differences
The evidence on record, AOD-9604: 6 cited studies, all animal or cell work. no human study. And Tesamorelin: 8 cited studies; 8 controlled trials in people.
No published study has set AOD-9604 against Tesamorelin head to head. The figures above come from separate studies of each compound, so the two columns are not the output of a single experiment.
Both are provided strictly for in-vitro laboratory research, and neither is meant for human or veterinary use.
FAQ
How do AOD-9604 and Tesamorelin differ?
AOD-9604 is modified c-terminal fragment of human growth hormone, whereas Tesamorelin is growth hormone-releasing hormone (ghrh) analogue. The table above breaks down each size, the per-milligram price, the evidence behind each compound and where each stands in Canada.
Which of AOD-9604 and Tesamorelin has more published research?
AOD-9604 lists 6 cited studies on its page and Tesamorelin lists 8. A higher count is not a mark of quality: the model behind each study counts for more, and both pages record that for every paper.
Are AOD-9604 and Tesamorelin authorized for sale in Canada?
For AOD-9604: No Drug Identification Number; named in a Health Canada advisory. For Tesamorelin: Ingredient is in an authorized Canadian medicine (a different product). Health Canada authorizes a drug by assigning an eight-digit Drug Identification Number, and most research peptides hold none.
Can AOD-9604 and Tesamorelin be combined?
No published study has examined the two in combination, so there is no evidence on what pairing them does. We supply both for laboratory research and make no claim about using them together.